Clinical-state biopharmaceutical company
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | FORBES-TATE |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2026 | FORBES-TATE |
1st Quarter (Jan 1 - Mar 31) AMENDED |
— |
| Firm | Filings | Expenses |
|---|---|---|
| FORBES-TATE | 21 | — |
| Issue | Activities |
|---|---|
| Health Issues | 21 |
| Budget/Appropriations | 2 |